文献速递胸部外周血管MRPET

非增强MR血管成像与平面V/Q闪烁显像诊断肺栓塞的诊断性能比较:系统评价与Meta分析

Comparison of the diagnostic performance of non-contrast MR angiography and planar V/Q scintigraphy for pulmonary embolism: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2025-01-26

该系统评价与Meta分析纳入8项MRI研究和9项V/Q研究,比较非增强磁共振肺动脉血管成像(NC-MRPA)与V/Q闪烁显像诊断急性肺栓塞的性能。NC-MRPA汇总敏感度0.88、特异度0.97、AUC 0.92;V/Q扫描汇总敏感度0.81、特异度0.84、AUC 0.87;V/Q非诊断性检查比例34.7%高于NC-MRPA的3.31%。结论提示NC-MRPA特异度高于V/Q闪烁显像,准确性和敏感度相当,非诊断性扫描更少,是静脉对比剂使用存在实质性风险患者的可行替代影像方法。

要点

  • NC-MRPA诊断PE汇总敏感度0.88、特异度0.97,AUC 0.92。
  • V/Q闪烁显像汇总敏感度0.81、特异度0.84,AUC 0.87。
  • V/Q非诊断性检查比例34.7%,高于NC-MRPA的3.31%。

核心结论

  • Meta分析提示NC-MRPA检测PE的特异度高于V/Q闪烁显像,准确性和敏感度相当,非诊断性扫描更少,是静脉对比剂使用存在实质性风险患者诊断PE的可行替代影像方法。

研究设计与样本

  • 系统评价与Meta分析,系统检索2000年至2024年电子数据库,共识别3709项研究(其中NC-MRPA研究1941项),最终纳入8项已发表MRI研究和9项已发表V/Q研究;主要结局为按患者的敏感度和特异度,采用随机效应分析计算汇总值、95%CI、SROC曲线及AUC。

诊断标准与关键数值

  • NC-MRPA汇总敏感度0.88(95%CI 0.83-0.91)、特异度0.97(95%CI 0.93-0.98),AUC 0.92(95%CI 0.85-0.96)。
  • V/Q闪烁显像汇总敏感度0.81(95%CI 0.76-0.85)、特异度0.84(95%CI 0.74-0.91),AUC 0.87(95%CI 0.75-0.91)。
  • V/Q扫描非诊断性检查汇总比例34.7%(95%CI 30.8-38.7),NC-MRPA研究为3.31%(95%CI 1.65-4.97)。

临床应用与阅片要点

  • 作者认为NC-MRPA是静脉碘对比剂使用存在实质性风险患者诊断PE的可行替代影像方法。
  • NC-MRPA与V/Q闪烁显像诊断PE的敏感度相似、特异度更高,且无电离辐射暴露。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To conduct a meta-analysis of the diagnostic performance of non-contrast magnetic resonance pulmonary angiography (NC-MRPA) and ventilation-perfusion (V/Q) scintigraphy for the detection of acute pulmonary embolism (PE).

MATERIALS AND METHODS: Systematic searches of electronic databases were conducted from 2000 to 2024. Primary outcomes were per-patient sensitivity and specificity of NC-MRPA and V/Q scintigraphy. The pooled sensitivities, specificities, and 95% confidence intervals (95% CI) were calculated using a random-effect analysis. Summary receiver-operating characteristic (SROC) curves and the area under the curve (AUC) were obtained.

RESULTS: A total of 3709 studies (1941 NC-MRPA studies) were identified through systematic searches, with eight published MRI and nine published V/Q investigations meeting inclusion criteria. The results showed that NC-MRPA had a pooled sensitivity of 0.88 (95% CI: 0.83-0.91) and specificity of 0.97 (95% CI: 0.93-0.98), yielding an AUC of 0.92 (95% CI: 0.85-0.96). V/Q scanning had a pooled sensitivity of 0.81 (95% CI: 0.76-0.85) and specificity of 0.84 (95% CI: 0.74-0.91), yielding an AUC of 0.87 (95% CI: 0.75-0.91). The pooled proportion of non-diagnostic tests for V/Q scans (34.7%, 95% CI: 30.8-38.7) was greater than that of NC-MRPA studies (3.31%, 95% CI: 1.65-4.97).

CONCLUSION: This meta-analysis suggests that NC-MRPA is more specific than V/Q scintigraphy for the detection of PE, with comparable accuracy and sensitivity. NC-MRPA yielded fewer non-diagnostic scans than V/Q scintigraphy and is a feasible alternative imaging modality for diagnosing PE in patients for whom intravenous contrast administration poses a substantive risk.

KEY POINTS: Question V/Q lung scintigraphy has been used as a reserve, alternative modality for patients who cannot undergo CT pulmonary angiography. Findings Non-contrast MR angiography (MRA) is a feasible alternative for diagnosing PE in patients for whom intravenous iodinated contrast administration poses a substantial risk. Clinical relevance Non-contrast MRA provides similar sensitivity and superior specificity to V/Q scintigraphy for diagnosing PE, without ionizing radiation exposure.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Silva RF, Zanon M, Ackman JB, et al. Comparison of the diagnostic performance of non-contrast MR angiography and planar V/Q scintigraphy for pulmonary embolism: a systematic review and meta-analysis. Eur Radiol. 2025. PMID: 39863727. doi:10.1007/s00330-025-11366-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。